PharPoint’s central nervous system experts include members of our clinical and biometric teams as well as key technology partners. The CNS team brings your central nervous system therapies to market faster, because we know patients are waiting for them.
PharPoint’s team has experience with Schedule I & II drugs. We’ve participated in numerous regulatory submissions for both the FDA’s neurology and analgesic divisions. In addition to an extensive CNS background, our team holds impressive rare disease experience. PharPoint has participated in 7 approved rare disease NDA/MAA/JNDA submissions, and has supported over 150 rare disease trials, many of which were central nervous system studies.
PharPoint can help clients isolate the unique challenges associated with CNS studies, including:
• Maximizing ease of study participation for patients and their caretakers
• Handling missing data due to study dropouts and missed assessments
• Ensuring rater consistency to clearly measure efficacy endpoint data
Minimize risk with a network of
, staff, and a study approach.
Through collaboration with key technology providers, PharPoint offers flexible virtual solutions for sponsors. This includes a platform for telemedicine visits, visiting clinician support to complete study procedures, support for the home delivery of IP, and a platform for the collection of ePRO, ClinRO, and eCRO.
Need a CNS CRO with the right expertise?
PharPoint’s CNS experience includes:
Want more information about PharPoint’s CNS experience?
Contact us to see what expertise we can bring to your study, or for a ballpark or comprehensive proposal.